Karen Knudsen, Chief Executive Officer at Parker Institute for Cancer Immunotherapy, shared a post on LinkedIn:
“Brilliant start to the Parker Institute for Cancer Immunotherapy at Dana-Farber Cancer Institute symposium on advances in immunotherapy.
Keynote E. John Wherry from PICI at University of Pennsylvania School of Medicine unveiled new data on the “process” that is T cell exhaustion, and how to mitigate.
Potentially game changing implications for how to sequence PD1 blockade in cancer therapy?!”
Other articles featuring Karen Knudsen on OncoDaily.